These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15268645)

  • 1. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.
    Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe IM; Houssiau F; Huizinga T; Isenberg D; Kallenberg CG; Khamashta M; Piette JC; Schneider M; Smolen J; Sturfelt G; Tincani A; van Vollenhoven R; Gordon C; Boumpas DT;
    Ann Rheum Dis; 2008 Feb; 67(2):195-205. PubMed ID: 17504841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGL1-LAG3 axis impairs IL-10-Producing regulatory T cells associated with Systemic lupus erythematosus disease activity.
    Chen K; Li X; Shang Y; Chen D; Qu S; Shu J; Zhang M; Wang Z; Huang J; Wu M; Ming S; Wu Y
    Heliyon; 2023 Oct; 9(10):e20806. PubMed ID: 37916085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations.
    Dar S; Koirala S; Khan A; Bellary MD; Patel AV; Mathew B; Singh R; Baigam N; Razzaq W; Abdin ZU; Khawaja UA
    Cureus; 2023 Aug; 15(8):e43725. PubMed ID: 37727166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune liver diseases in systemic rheumatic diseases.
    Wang CR; Tsai HW
    World J Gastroenterol; 2022 Jun; 28(23):2527-2545. PubMed ID: 35949355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Contribution of Drugs and
    Reshetnyak TM; Doroshkevich IA; Seredavkina NV; Nasonov EL; Maev IV; Reshetnyak VI
    Int J Rheumatol; 2019; 2019():9698086. PubMed ID: 31191660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis.
    Bessone F; Poles N; Roma MG
    World J Hepatol; 2014 Jun; 6(6):394-409. PubMed ID: 25018850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role.
    Al Hussaini M; Hammouda EI; Hammouda AE
    Int J Clin Pharm; 2014 Aug; 36(4):684-92. PubMed ID: 24986265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pragmatic approaches to therapy for systemic lupus erythematosus.
    Xiong W; Lahita RG
    Nat Rev Rheumatol; 2014 Feb; 10(2):97-107. PubMed ID: 24166241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
    Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J
    J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.
    Horizon AA; Wallace DJ
    Expert Opin Drug Saf; 2004 Jul; 3(4):273-8. PubMed ID: 15268645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.
    Ostensen M; Villiger PM
    Lupus; 2000; 9(8):566-72. PubMed ID: 11035430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.
    Østensen M; Villiger PM
    Lupus; 2001; 10(3):135-9. PubMed ID: 11315341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE.
    Lander SA; Wallace DJ; Weisman MH
    Lupus; 2002; 11(6):340-7. PubMed ID: 12139371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aseptic meningo-encephalitis related to dexibuprofen use in a patient with systemic lupus erythematosus: a case report with MR findings.
    Obermoser G; Bellmann R; Pfausler B; Schmutzhard E; Sepp N
    Lupus; 2002; 11(7):451-3. PubMed ID: 12195787
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.